This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (482)

Published on in Vol 9 , No 7 (2020) :July

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/19598, first published .
Gaining First Insights on Secondary Progressive Multiple Sclerosis Patients Treated With Siponimod in Clinical Routine: Protocol of the Noninterventional Study AMASIA

Gaining First Insights on Secondary Progressive Multiple Sclerosis Patients Treated With Siponimod in Clinical Routine: Protocol of the Noninterventional Study AMASIA

Gaining First Insights on Secondary Progressive Multiple Sclerosis Patients Treated With Siponimod in Clinical Routine: Protocol of the Noninterventional Study AMASIA

Authors of this article:

Tjalf Ziemssen 1 Author Orcid Image ;   Olaf Hoffmann 2 Author Orcid Image ;   Luisa Klotz 3 Author Orcid Image ;   Herbert Schreiber 4 Author Orcid Image ;   Martin S Weber 5, 6 Author Orcid Image ;   Benedict Rauser 7 Author Orcid Image
Article Authors Cited by (14) Tweetations (4) Metrics

Tjalf Ziemssen   1 , Prof Dr ;   Olaf Hoffmann   2 , PD ;   Luisa Klotz   3 , Prof Dr ;   Herbert Schreiber   4 , Prof Dr ;   Martin S Weber   5, 6 , Prof Dr ;   Benedict Rauser   7 , PhD

1 Department of Neurology, Center of Clinical Neuroscience, Carl Gustav Carus University Clinic, University Hospital of Dresden, Dresden, Germany

2 Department of Neurology, St Josefs-Krankenhaus, Potsdam, Germany

3 Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany

4 Neurological Practice Center, NTD & Neuropoint Academy, Ulm, Germany

5 Institute of Neuropathology, University Medical Center Goettingen, Goettingen, Germany

6 Department of Neurology, University Medical Center Goettingen, Goettingen, Germany

7 Novartis Pharma GmbH, Nuremberg, Germany

Corresponding Author: